Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study

References

• Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–1656. doi:10.1016/S0140-6736(19)30308-3
   PubMed Web of Science ®Google Scholar
• Zaman K. Tuberculosis: a global health problem. J Heal Popul Nutr. 2010;28(2):111.
   PubMed Web of Science ®Google Scholar
• Friedman LN, Dedicoat M, Davies PD. Clinical Tuberculosis. 6th ed. Vol. 53; 2020.
   Google Scholar
• Allué-Guardia A, García JI, Torrelles JB. Evolution of drug-resistant mycobacterium tuberculosis strains and their adaptation to the human lung environment. Front Microbiol. 2021;12. doi:10.3389/fmicb.2021.612675
   Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2020 [Internet]. World Health Organization; 2020 [cited February 17, 2022]. Available from: https://www.who.int/publications/i/item/9789240013131. Accessed May 27, 2022.
   Google Scholar
• World Health Organization. Global tuberculosis report 2021 [Internet]. Geneva: World Health Organization; 2021 [cited February 17, 2022]. Available from: https://www.who.int/publications/i/item/9789240037021. Accessed May 27, 2022.
   Google Scholar
• World Health Organization. The end TB strategy [Internet]. World Health Organization; 2015 [cited February 17, 2022]. Available from: https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19. Accessed May 27, 2022.
   Google Scholar
• Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–1567. doi:10.1111/jam.14478
   PubMed Web of Science ®Google Scholar
• Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis, an update on disease burden, diagnosis and treatment. Respirology. 2018;23(7):656–673. doi:10.1111/resp.13304
   PubMed Web of Science ®Google Scholar
• Mariandyshev A, Eliseev P. Drug-resistant tuberculosis threatens WHO’s End-TB strategy. Lancet Infect Dis. 2017;17(7):674–675. doi:10.1016/S1473-3099(17)30246-3
   Web of Science ®Google Scholar
• Pai M, Memish ZA. Antimicrobial resistance and the growing threat of drug-resistant tuberculosis. J Epidemiol Glob Health. 2016;6(2):45. doi:10.1016/j.jegh.2016.02.001
   Google Scholar
• World Health Organization. Tuberculosis, multidrug-resistant tuberculosis (MDR-TB) [Internet]. World Health Organization; 2018 [cited February 17, 2022]. Available from: https://www.who.int/news-room/questions-and-answers/item/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb). Accessed May 27, 2022.
   Google Scholar
• Kendall EA, Fofana MO, Dowdy DW. The burden of transmitted multi-drug resistance among epidemics epidemics of tuberculosis, a transmission model. Lancet Respir Med. 2015;3(12):963–972. doi:10.1016/S2213-2600(15)00458-0
   Web of Science ®Google Scholar
• World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4, treatment - drug-resistant tuberculosis treatment. [Internet]. Geneva: World Health Organization; 2020 [cited February 16, 2022]. Available from: https://www.who.int/publications/i/item/9789240007048. Accessed May 27, 2022.
   Google Scholar
• Lecai J, Mijiti P, Chuangyue H, et al. Predictors and trends of MDR/RR-TB in Shenzhen China: a retrospective 2012–2020 period analysis. Infect Drug Resist. 2021;14:4481–4491. doi:10.2147/IDR.S335329
   Web of Science ®Google Scholar
• Federal Ministry of Health of Ethiopia. Guidelines for Clinical and Programmatic Management of TB, TB/ HIV, DR-TB and Leprosy in Ethiopia. 7th ed. Addis Ababa: Ministry of Health - Ethiopia; 2021.
   Google Scholar
• World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment [Internet]. Geneva: World Health Organization; 2019 [cited February 17, 2022]. Available from: https://www.who.int/publications/i/item/9789241550529. Accessed May 27, 2022.
   Google Scholar
• World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
   Google Scholar
• Olupot-Olupot P, Namuyodi D, Obbo JSO, Meadway J. Multidrug resistant tuberculosis (MDR-TB) in emerging economies in Sub-Saharan Africa, clinicians’ public health concerns. J Public Heal Emerg. 2017;1:43. doi:10.21037/jphe.2017.03.01
   Google Scholar
• Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185–192. doi:10.2147/IDR.S135935
   PubMed Web of Science ®Google Scholar
• Tola H, Holakouie-Naieni K, Mansournia MA, et al. National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia, a 10-year retrospective cohort study. BMJ Open. 2021;11(8):e040862. doi:10.1136/bmjopen-2020-040862
   Web of Science ®Google Scholar
• Alemu A, Bitew ZW, Worku T. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia, a systematic review and meta-analysis. Int J Infect Dis. 2020;98:420–439. doi:10.1016/j.ijid.2020.05.087
   Web of Science ®Google Scholar
• World Health Organization. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions [Internet]. Geneva; 2021 [cited March 4, 2022]. Available from: https://www.who.int/publications/i/item/9789240022195. Accessed May 27, 2022.
   Google Scholar
• World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision [Internet]. Geneva: World Health Organization; 2013 [cited March 4, 2022]. Available from: https://www.who.int/publications/i/item/9789241505345. Accessed May 27, 2022.
   Google Scholar
• World Health Organization. Implementing the End TB Strategy, the essentials [Internet]. Geneva: World Health Organization; 2015 [cited March 4, 2022]. Available from: https://www.who.int/tb/publications/2015/end_tb_essential.pdf. Accessed May 27, 2022.
   Google Scholar
• Aragaw N, Teferi M, Ali O, et al. Treatment outcomes and predictors of outcome in Multidrug Resistance Tuberculosis (MDR-TB) cohort of patients in Addis Ababa, Ethiopia. Am J Heal Res. 2021;9(5):204. doi:10.11648/j.ajhr.20210905.19
   Google Scholar
• Bogale L, Tsegaye T, Abdulkadir M, Akalu TY. Unfavorable treatment outcome and its predictors among patients with multidrug-resistance tuberculosis in southern Ethiopia in 2014 to 2019, a multi-center retrospective follow-up study. Infect Drug Resist. 2021;14:1343–1355. doi:10.2147/IDR.S300814
   PubMed Web of Science ®Google Scholar
• Baye AM, Demisis Sarhie W, Endalew BT. Treatment outcomes of multi-drug-resistant tuberculosis and its determinants in Boru Meda Hospital, Northeast Ethiopia. J Infect Dis Ther. 2018;06(01). doi:10.4172/2332-0877.1000350
   Google Scholar
• Alene KA, Viney K, McBryde ES, Tsegaye AT, Clements ACA. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia. Trop Med Int Heal. 2017;22(3):351–362.
   PubMed Web of Science ®Google Scholar
• Eshetie S, Alebel A, Wagnew F, Geremew D, Fasil A, Sack U. Current treatment of multidrug resistant tuberculosis in Ethiopia, an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens 11 Medical and Health Sciences 1117 Public Health and Health Services. BMC Infect Dis. 2018;18(1):1–0.
   Google Scholar
• Wakjira MK, Sandy PT, Mavhandu-Mudzusi AH. Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia. PLoS One. 2022;17(2):e0262318. doi:10.1371/journal.pone.0262318
   Web of Science ®Google Scholar
• Eshetie S, Alebel A, Wagnew F, Geremew D, Fasil A, Sack U. Current treatment of multidrug resistant tuberculosis in Ethiopia, an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens. BMC Infect Dis. 2018;18(1),486. doi:10.1186/s12879-018-3401-5
   Web of Science ®Google Scholar
• Kassa GM, Tadesse A, Gelaw YA, et al. Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia, a retrospective follow-up study. Epidemiol Infect. 2020;15(148):e258. doi:10.1017/S0950268820002514
   Web of Science ®Google Scholar
• Murali S, Krishnamoorthy Y, Knudsen S, et al. Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India. PLoS One. 2021;16(8):e0256773. doi:10.1371/journal.pone.0256773
   PubMed Web of Science ®Google Scholar
• Van LH, Phu PT, Vinh DN, et al. Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City, a retrospective study. BMC Infect Dis. 2020;20(1),164. doi:10.1186/s12879-020-4887-1
   Web of Science ®Google Scholar
• Byng-Maddick R, Noursadeghi M. Does tuberculosis threaten our ageing populations? BMC Infect Dis. 2016;16(1),119. doi:10.1186/s12879-016-1451-0
   PubMed Web of Science ®Google Scholar
• Schaaf HS, Collins A, Bekker A, Davies PDO. Tuberculosis at extremes of age. Respirology. 2010;15(5),747–763. doi:10.1111/j.1440-1843.2010.01784.x
   PubMed Web of Science ®Google Scholar
• Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001;33(7),1034–1039. doi:10.1086/322671
   Web of Science ®Google Scholar
• Teferi MY, Didana LD, Hailu T, Woldesenbet SG, Bekele S, Mihret A. Tuberculosis treatment outcome and associated factors among tuberculosis patients at Wolayta Sodo Teaching and Referral Hospital, Southern Ethiopia, a retrospective study. J Public Health Res. 2021;10:jphr.2021.2046. doi:10.4081/jphr.2021.2046
   Web of Science ®Google Scholar
• Ali MH, Alrasheedy AA, Kibuule D, Godman B, Hassali MA, Ali HMH. Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications. Expert Rev Anti Infect Ther. 2019;17(11),927–937. doi,10.1080/14787210.2019.1689818
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310,45.
   Web of Science ®Google Scholar